[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Handa et al., 1985 - Google Patents

Defining cytolytic T lymphocyte recognition of chemically modified self. I. Response to trinitrophenyl-H-2Kk.

Handa et al., 1985

View PDF
Document ID
15697902719756168192
Author
Handa K
Herrmann S
Publication year
Publication venue
Journal of immunology (Baltimore, Md.: 1950)

External Links

Snippet

We used purified class I antigen incorporated into liposomes to examine the response of secondary cytolytic T lymphocytes (CTL) to chemically modified self. By generating the secondary response in the presence of T cell helper factor, the level of CTL response was …
Continue reading at scholar.archive.org (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens

Similar Documents

Publication Publication Date Title
Armerding et al. Activation of T and B lymphocytes in vitro: II. Biological and biochemical properties of an allogeneic effect factor (AEF) active in triggering specific B lymphocytes
Adorini et al. Mechanisms influencing the immunodominance of T cell determinants.
EP0423201B1 (en) Mhc-mediated conjugates useful in ameliorating autoimmunity
Solinger et al. T-lymphocyte response to cytochrome c. I. Demonstration of a T-cell heteroclitic proliferative response and identification of a topographic antigenic determinant on pigeon cytochrome c whose immune recognition requires two complementing major histocompatibility complex-linked immune response genes.
Gay et al. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen
EP0304279B1 (en) Peptide determinant associated with immunity
EP0146266A2 (en) Enzyme-resistant immunomodulatory peptides
Demotz et al. Processing of tetanus toxin by human antigen-presenting cells. Evidence for donor and epitope-specific processing pathways.
WO1995026980A2 (en) Haptenated peptides and uses thereof
US20140295550A1 (en) Hla peptide therapy
Mescher et al. The induction of secondary cytolytic T lymphocytes by solubilized membrane proteins.
Handa et al. Defining cytolytic T lymphocyte recognition of chemically modified self. I. Response to trinitrophenyl-H-2Kk.
Kiger et al. Some effects of a partially purified lymphocyte-inhibiting factor from calf thymus
Glant Induction of cartilage degradation in experimental arthritis produced by allogeneic and xenogeneic proteoglycan antigens
Tsuchida et al. Epidermal Langerhans cells can function as stimulatory cells but not as accessory cells in CTL induction.
Levy et al. Role of self and foreign antigenic determinants in allogeneic and self-restricted cytotoxic T cell recognition.
Engelhard et al. Cytotoxic T lymphocyte recognition of HLA-A/B antigens introduced into EL4 cells by cell-liposome fusion.
Griscelli et al. Combined immunodeficiency with abnormal expression of MHC class II genes
Suzuki et al. Suppressive B-cell factor (SBF) produced by FcR-bearing B cells; suppression of B, but not non-B-cell proliferation.
Mecheri et al. Immunogenic peptides require an undisturbed phospholipid cell membrane environment and must be amphipathic to immobilize Ia on B cells.
Jang et al. T cell epitope recognition involved in the low-responsiveness to a region of hen egg lysozyme (46–61) in C57BL/6 mice
EP0773789B1 (en) Use of MHC xenoantigen in the manufacture of a medicament for the treatment of cancer
Reisfeld et al. Human histocompatibility antigens
Voigtmann et al. The preparation and purification of HL‐A monospecific antigens using platelets and various lymphoid sources
Méndez-Samperio et al. Peptide competition at the level of MHC-binding sites using T cell clones from a rheumatoid arthritis patient